Acadia pulls trials of pimavanserin after schizophrenia fail
pharmaphorum,
Acadia Pharma’s plan to develop pimavanserin as a treatment for additional indications is in disarray after the drug failed a…
Acadia Pharma’s plan to develop pimavanserin as a treatment for additional indications is in disarray after the drug failed a…
Every relationship has its ups and downs, but when one person is diagnosed with schizophrenia, it’s possible for partnerships…